High-dose therapy and autologous hematopoietic cell transplantation as front-line consolidation in chronic lymphocytic leukemia: a systematic review.

about

Reappraising the timing of transplant for indolent non-Hodgkin lymphomas.Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.

P2860

Q30248407-F454D596-BA70-4A2D-8B10-2AB0325024F0 Q38962267-76949E77-82CF-4390-A734-70565A90A482

P2860

High-dose therapy and autologous hematopoietic cell transplantation as front-line consolidation in chronic lymphocytic leukemia: a systematic review.

Item

http://www.wikidata.org/entity/Q38418199

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

High-dose therapy and autologo ...... leukemia: a systematic review.

@en

type

Item

label

High-dose therapy and autologo ...... leukemia: a systematic review.

@en

prefLabel

High-dose therapy and autologo ...... leukemia: a systematic review.

@en

P1476

High-dose therapy and autologo ...... leukemia: a systematic review.

@en

P2093

A Kumar

http://www.w3.org/2001/XMLSchema#string

B Djulbegovic

http://www.w3.org/2001/XMLSchema#string

M A Kharfan-Dabaja

http://www.w3.org/2001/XMLSchema#string

P2860

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Quantifying heterogeneity in a meta-analysis

Genomic aberrations and survival in chronic lymphocytic leukemia

Idelalisib and rituximab in relapsed chronic lymphocytic leukemia

Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia

Optimal search strategies for retrieving scientifically strong studies of treatment from Medline: analytical survey.

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial.

Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents?

Systematic review of high dose chemotherapy and autologous haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: what is the published evidence?

Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia.

P2888

bmt.2015.69

P304

1069-1074

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2015.69

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tea Reljic

P577

2015-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274900388

http://www.w3.org/2001/XMLSchema#string

P6179

1007111869

http://www.w3.org/2001/XMLSchema#string

P698

25867647

http://www.w3.org/2001/XMLSchema#string

P921

lymphocyte

High-dose therapy and autologous hematopoietic cell transplantation as front-line consolidation in chronic lymphocytic leukemia: a systematic review.

about

P2860

P2860

High-dose therapy and autologous hematopoietic cell transplantation as front-line consolidation in chronic lymphocytic leukemia: a systematic review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P6179

P698

P921